[#item_full_content]
EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program
2024-10-24T11:01:33-04:00October 24th, 2024|
Related Posts
-
Virtu Financial Q3: Earnings Beat, Revenue Surge, Dividend Payout & More
October 24th, 2024 -
KKR Joins Half-Trillion Club in Private Markets’ Race for Scale
October 24th, 2024 -
Pool Corporation Reports Q3 Earnings: Key Takeaways
October 24th, 2024 -
Selling Stock Concentration Is the ETF Industry’s New Big Idea
October 24th, 2024